Decreto 173/2022 - INCORPORACION AL ORDENAMIENTO JURIDICO INTERNO LA RESOLUCION GMC N° 02/21, POR LA CUAL SE APROBARON LOS "CRITERIOS MINIMOS PARA LA APLICACION DE ANALISIS DE RIESGO DE LA CLASIFICACION DE DEFICIENCIAS EN BUENAS PRACTICAS DE FABRICACION DE MEDICAMENTOS" — Uruguay law | Esheria

Decreto 173/2022 - INCORPORACION AL ORDENAMIENTO JURIDICO INTERNO LA RESOLUCION GMC N° 02/21, POR LA CUAL SE APROBARON LOS "CRITERIOS MINIMOS PARA LA APLICACION DE ANALISIS DE RIESGO DE LA CLASIFICACION DE DEFICIENCIAS EN BUENAS PRACTICAS DE FABRICACION DE MEDICAMENTOS"

This decree incorporates MERCOSUR Resolution GMC N° 02/21 into Uruguay’s national legal order and says the decree takes effect when it is published in the Official Gazette.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
Uruguay
Instrument
Decree law
Version
Undated source snapshot
Language
es
Official source
View official record ↗
good manufacturing practices pharmaceutical manufacturing regulatory compliance risk analysis

Publicly available, excluded from search-engine indexing

This page remains available for direct access and API use, but this release emits noindex,follow for the following reason:

  • The record does not meet this release's canonical indexing criteria. (market-indexing-disabled)

Statute overview

About this statute

This page preserves the statute’s identified version, provision structure, official source link, and stored legal text for reading and research.